IP2

IP2 is a non-cytotoxic immunomodulator that promotes the presentation of Pioneer Translation Product (PTP) -derived antigens in cancer cells. It has demonstrated efficacy in impairing tumor growth in murine models, supporting its use in immuno-oncology research for both in vitro antigen presentation studies and in vivo therapeutic investigations.